The patient was submitted to 2-stage operations. Cardiac and vascular surgery as the first-stage procedure was performed under general anesthetic and with extracorporeal circulation. A mass of 6 cm Â 6 cm Â 3 cm was resected from the right atrial. The histological images (hematoxylin and eosin) revealed fusiform smooth muscle cells arranged in a bundle and vascular hyaline degeneration in the tumor. Immunohistochemical staining (DAKO or Abcam, Hong Kong, China) displayed S-100 (-), cytokeratin pan (CKP) (-), Desmin (+), vimentin (1+), smooth muscle actin (SMA) (2+), CD31 (1+), CD68 (+), CD34 (vascular endothelium+), myoD1 (-), and ki67 (<10%), respectively. Morphology and immunohistochemistry supported angioleiomyoma [ Figure 1E -1K]. In the second-stage operation, the patient underwent panhysterectomy, bilateral salpingo-oophorectomy, and myomectomy of inferior vena cava. Two 30-cm long masses were removed from inferior vena cava. Pathological examination showed the spindleshaped tumor cells were arranged in a knit-like and bunchlike formation, and exhibited rare mitotic figures [ Figure 1L ]. Immunohistochemical staining displayed D2-40 (endothelial cells of tumor location [-] ), estrogen receptor (ER) (75%), progesterone receptor (PR) (75%), ki67 (5%), SMA (3+), Desmin (3+), CD34 (vascular endothelium+), vimentin (1+), p53 (-), CD31 (vascular endothelium+), Factor VIII (vascular endothelium+), and S-100 (-), respectively. The diagnosis was intravenous leiomyomatosis (IVL). No recurrence of the tumor was observed during the follow-up for 9 months.
IVL occurs in female subjects aged 33 to 54 years (average age, 44 years). Those patients usually had a history of uterine fibroids or hysterectomy. [1] The clinical characteristics of IVL depend on the scale and location of liomyoma. The patients with IVL usually lack typical clinical symptoms, and early diagnosis was difficult. The pathogenesis of IVL remains unclear until now. Mainly there are 2 etiological theories about the origin of IVL. In most cases, IVL was assumed to arise from the local extension of myometrial smooth muscle cells into adjacent venous channels of the pelvic cavity. Less commonly, IVL was believed to derive from smooth muscle in the vessel wall. [2] In addition, Kir et al [3] reported the patient of IVL with high levels of estradiol and estrogen receptor. However, the endothelial cells and subendothelial cells in the vessel wall had little estrogen receptor or progesterone receptor expression. The recent studies also suggested normal myometrium and IVL were strongly positive for desmin, while the smooth muscle cells in the vascular wall did not express the feature of desmin. [4] More evidence supports the origin of IVL from myometrial smooth muscle cells, which may be an explanation why IVL and uterine fibroids are mostly concomitant. The recurrence rate of IVL was 30%, surgery still was the preferred option for its treatment. [5] Hormonal therapy was also used in the past decade. However, the efficacy of antiestrogenic drugs, such as tamoxifen and gonadotrophin-releasing hormone agonist (GnRHa), has yet to be established. [6] In conclusion, IVL as a rare disease, early detection, and timely treatment is necessary for it. Once the imaging presents the mass of uterine or periuterine, and extensive intravenous extension, IVL must be considered. Following the discovery, surgery will be initiated. Therapeutic process warrants a close cooperation of the multidisciplinary team. Given the high recurrence of this disease, close long-term follow-up is also critical.
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